RUSERONTINIB

SynDRA canonical compound SYN0038388 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	EGFR \| FLT3
Mechanism of action	Abl kinase inhibitor \| EGFR inhibitor \| FLT3 inhibitor

All known targets

FLT3
EGFR
ABL1

Mechanisms of action (all sources)

EGFR INHIBITOR
Epidermal growth factor receptor erbB1 inhibitor
FLT3 INHIBITOR
Tyrosine-protein kinase receptor FLT3 inhibitor
ABL1 INHIBITOR
Tyrosine-protein kinase ABL inhibitor
Abl kinase inhibitor

Cross-references

PubChem CID: 54760385
ChEMBL: CHEMBL3678958
DrugBank: DB21555

Synonyms

SKLB-1028
Sklb1028
SKLB 1028
AQ3TTU8UM7
RefChem:180331
Multikinase Inhibitor SKLB1028
EGFR/FLT3/Abl Inhibitor SKLB1028
Ruserontinib [INN]
SKLB-?1028
MFCD30471083
Ruserontinib [WHO-DD]
UNII-AQ3TTU8UM7
orb1695203
SCHEMBL12065086
SCHEMBL29386242
GTPL12089
BDBM173454
C24H29N9
AKOS030629098
EBC-609318
SB18853
DA-77591
TS-08798
HY-120590
T34656
US9096601, 8-29

Look up RUSERONTINIB in the interactive SynDRA portal →